The Research and Development team at Cyprotex focuses on advancing innovative methodologies in ADME-Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity) through high-throughput screening, customized assays, and predictive modeling. By leveraging in vitro toxicology and cutting-edge analytical techniques, the team aims to enhance drug development efficiency and safety, supporting the broader goals of the Evotec Group from discovery to clinical development.